HLH Syndrome Post Dengue
For dengue-triggered HLH, initiate treatment with high-dose corticosteroids (dexamethasone 10 mg/m² daily) for 3-4 days as first-line therapy, reserving etoposide only for severe cases with imminent organ failure or rapid clinical deterioration.
Treatment Approach Based on Disease Severity
Mild to Moderate Dengue-Associated HLH
The treatment strategy for dengue-triggered HLH differs fundamentally from other viral HLH triggers due to dengue's self-limited nature and favorable outcomes with conservative management.
Start with corticosteroids alone 1, 2:
- Dexamethasone 10 mg/m² daily for 3-4 days (short course)
- Alternative: Prednisolone 1-2 mg/kg daily
- Consider adding IVIG 1.6 g/kg divided over 2-3 days 1
Multiple case reports demonstrate successful resolution with steroid monotherapy alone, with treatment courses ranging from 4-8 weeks 2, 3, 4. Notably, some cases have even resolved with supportive care only, without steroids 5, though this should not be the default approach given HLH's high mortality risk.
Severe Dengue-Associated HLH with Organ Failure
Add etoposide only if 1:
- Imminent organ failure present
- Rapid clinical deterioration despite corticosteroids
- No response to initial steroid therapy within 48-72 hours
When etoposide is necessary:
- Modified dosing: 50-100 mg/m² once weekly (reduced from standard 150 mg/m² twice weekly) 1
- Use sparingly because bone marrow recovery is essential for immune reconstitution 1
- Monitor cumulative dose; stay below 2-3 g/m² total 1
Clinical Recognition
Suspect dengue-associated HLH when 2:
- Prolonged or recurrent fever >7 days after dengue diagnosis
- Persistent fever during or after the critical phase
- Anemia without intravascular hemolysis or massive bleeding
- Persistent cytopenias despite resolution of plasma leakage phase
- Hepatosplenomegaly developing during illness
Confirm diagnosis using HLH-2004 criteria (need ≥5 of 8) 2, 4:
- Fever
- Splenomegaly
- Cytopenias (≥2 lineages)
- Hypertriglyceridemia and/or hypofibrinogenemia
- Hemophagocytosis in bone marrow
- Low/absent NK cell activity
- Hyperferritinemia (>500 ng/mL, often >3000 ng/mL)
- Elevated soluble CD25
Key Differences from Standard HLH Management
The 2019 Blood guidelines emphasize graded treatment intensity based on disease severity 1. For infection-associated HLH, the guidelines state that "resolution of HLH without HLH-specific treatment has been observed, particularly in infection-associated HLH" 1.
Dengue-specific considerations:
- Dengue is self-limited, unlike EBV which may require prolonged immunosuppression
- The cytokine storm typically resolves as dengue infection clears
- Aggressive immunosuppression with full HLH-94 protocol (8 weeks etoposide + cyclosporine) is rarely necessary 2, 3
- Short steroid courses (3-4 days to 4-8 weeks) show excellent outcomes 2, 6, 3, 4
Monitoring and Response Assessment
Weekly reassessment should include 1:
- Ferritin levels (trend more important than absolute value)
- Soluble CD25 (sCD25)
- Complete blood counts
- Triglycerides and fibrinogen
- Clinical status (fever resolution, organomegaly regression)
Treatment can be tapered when:
- Fever resolves
- Cytopenias improve
- Ferritin trending downward
- Hepatosplenomegaly regressing
Critical Pitfalls to Avoid
Misdiagnosing as sepsis: Dengue-HLH overlaps clinically with sepsis; maintain high suspicion when fever persists beyond expected dengue timeline 7
Over-treatment: Unlike EBV-HLH which often requires full HLH-94 protocol, dengue-HLH typically responds to steroids alone. Avoid unnecessary etoposide exposure and its associated toxicities 1, 2
Under-recognition: HLH is often missed because clinicians focus solely on dengue management. Consider HLH in any severe dengue with unusual features 2, 8
Delayed diagnosis: Early recognition is crucial as mortality ranges from 20-88% in untreated adult HLH 1. Check ferritin, triglycerides, and consider bone marrow examination early when suspicion arises
Supportive Care
Regardless of immunosuppressive therapy chosen:
- Maintain platelet support as needed for dengue-related thrombocytopenia
- Monitor for plasma leakage (dengue critical phase)
- Avoid NSAIDs (use acetaminophen for fever)
- Consider antimicrobial prophylaxis if prolonged steroid therapy required 1
The favorable prognosis of dengue-associated HLH with steroid therapy alone distinguishes it from other viral triggers and justifies a more conservative initial approach 2, 3, 5.